Adrenaline and noradrenaline have been shown in different cancer cell lines to act via β-adrenergic receptor (β-AR) signaling leading to elevated secreted levels of VEGF facilitating tumor growth [22], effects blocked by cell treatment with the β-AR antagonist, propranolol [22,23,24]. Here, ADRB2 is linked to cancer.